Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (81-90 of 450) with videos related to

Pageof 45
Sort By:
Biological Research for Nursing|January 26, 2010
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugsMarilyn A Davies, Yvette Conley, Bryan L Roth
Current Topics in Medicinal Chemistry|June 8, 2002
Molecular biology of serotonin receptors structure and function at the molecular levelWesley K Kroeze, Kurt Kristiansen, Bryan L Roth
Cell Research|April 21, 2025
Orchestrating NTSR1 signaling from the interfaceXianglin Huang, Brian E Krumm, Bryan L Roth
Drug Discovery Today|July 19, 2006
Screening the receptorome: an efficient approach for drug discovery and target validationRyan T Strachan, Gina Ferrara, Bryan L Roth
Cell|July 29, 2017
How Ligands Illuminate GPCR Molecular PharmacologyDaniel Wacker, Raymond C Stevens, Bryan L Roth
Nature Chemical Biology|October 19, 2017
Discovery of new GPCR ligands to illuminate new biologyBryan L Roth, John J Irwin, Brian K Shoichet
Psychopharmacology|June 19, 2004
Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disordersBryan L Roth, S Mohammad Hanizavareh, Andrew E Blum
Nature Reviews. Drug Discovery|April 3, 2004
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophreniaBryan L Roth, Douglas J Sheffler, Wesley K Kroeze
Journal of Cell Science|November 20, 2003
G-protein-coupled receptors at a glanceWesley K Kroeze, Douglas J Sheffler, Bryan L Roth
Journal of Medicinal Chemistry|April 28, 2012
Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancersRima Hajjo, Vincent Setola, Bryan L Roth, et al.
Pageof 45

Showing results (81-90 of 450) with videos related to

Sort By:
Pageof 45
Biological Research for Nursing|January 26, 2010
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugsMarilyn A Davies, Yvette Conley, Bryan L Roth
Current Topics in Medicinal Chemistry|June 8, 2002
Molecular biology of serotonin receptors structure and function at the molecular levelWesley K Kroeze, Kurt Kristiansen, Bryan L Roth
Cell Research|April 21, 2025
Orchestrating NTSR1 signaling from the interfaceXianglin Huang, Brian E Krumm, Bryan L Roth
Drug Discovery Today|July 19, 2006
Screening the receptorome: an efficient approach for drug discovery and target validationRyan T Strachan, Gina Ferrara, Bryan L Roth
Cell|July 29, 2017
How Ligands Illuminate GPCR Molecular PharmacologyDaniel Wacker, Raymond C Stevens, Bryan L Roth
Nature Chemical Biology|October 19, 2017
Discovery of new GPCR ligands to illuminate new biologyBryan L Roth, John J Irwin, Brian K Shoichet
Psychopharmacology|June 19, 2004
Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disordersBryan L Roth, S Mohammad Hanizavareh, Andrew E Blum
Nature Reviews. Drug Discovery|April 3, 2004
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophreniaBryan L Roth, Douglas J Sheffler, Wesley K Kroeze
Journal of Cell Science|November 20, 2003
G-protein-coupled receptors at a glanceWesley K Kroeze, Douglas J Sheffler, Bryan L Roth
Journal of Medicinal Chemistry|April 28, 2012
Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancersRima Hajjo, Vincent Setola, Bryan L Roth, et al.
Pageof 45